Funded by the European Union's Horizon 2020 program.
'Integrating chemical and biological approaches to target NAD production and signaling in cancer.'
Our final meeting took place last week in Sheffield. Congratulations on the amazing progress and work of all our fellows over the last 3 years!
#scientists#cancerresearch#msca
If you want to know more about pyrimidine salvage and its potential role in improving current pyrimidine synthesis inhibitors in cancer then look no further:
https://t.co/0upePB54hy
@MDPIOpenAccess#cancer#AcademicTwitter
The 3rd Integrata Course on Transferable Skills on "Computer Aided Drug Design Approaches" and "Fund raising and grant proposal writing" took place remotely at the beginning of February. Thanks to @BioChemInf@ActaInnovation and all invited speakers.
#PhDlife#grantwriting
The synthesis and biological properties of all the iminosugars as glycosyltransferase inhibitors assayed to date are reviewed.
#iminosugars#cancerresearch#MSCA#H2020
Congratulations to our fellow @irene_conforti for the exhaustive review on the synthesis and glycosyltransferase inhibition properties of the iminosugars published in Organic & Biomolecular Chemistry (Royal Society of Chemistry, UK).
Check it out here:
https://t.co/5CTm4JWE84
Iminosugars are naturally occurring carbohydrates that, over the past five decades, have been mainly exploited to inhibit glycosidases. However, iminosugars are also inhibitors of glycosyltransferases, which are involved in cancer and bacterial infections.
Two weeks ago, our fellows were attending their next short course in transferable skills about 'business and financial analysis in drug discovery, patenting, entrepreneurship and regulatory affairs'. Thanks to @BioChemInf and @ActaInnovation for organising the course.
An interesting article of our fellow Moustafa S. Ghanem "Advances in NAD-Lowering Agents for Cancer Treatment" has been published in Nutrients (MDPI, Basel, Switzerland).
https://t.co/n0YKUHnB6L
#NADmetabolism#Cancerresearch#MSCA#H2020
It is part of the Special Issue Nicotinamide Adenine Dinucleotide (NAD) in Human Health and Disease.
The review describes the milestones and the recent advances in the field of exploiting NAD metabolism to combat cancer proliferation.
Exciting days ahead. Our fellows @AgataCarreira and @MelliW92 are presenting their projects at the @NEPGconference tomorrow.
The registration is still open, so feel free to join them 😊
🚨 BIG ANNOUNCEMENT 🚨
We are pleased to share with you all, the schedule for #NEPG2020!
Join us on Friday 13th November via Zoom!
We look forward to seeing you all!
Our fellow @MelliW92 was presenting her poster with the title "Development of small molecule NUDT22 inhibitors for uses in cancer" at the SYNTRAIN Genomic Instability conference this month. The conference should have taken place in March but due to COVID-19 was hold online.
Time has come! We are please to announce that SYNTRAIN is organizing a conference next March. Join us if you want to know what is the current status in genomic instability research from top field leaders.
Register here👇
https://t.co/LftVAYYAwW
The fellows had their first Integrata Transferable Skills Course in Scientific Communication in the last couple of days. Unfortunately it couldn't take place in Siena as planned. It was still really effective and a nice experience. Thank you @innacta for organising the course.